Whether your needs cover GLP/ GCP Bioanalysis, GMP Biopharma and Pharma analysis, GMP Auditing, Method development and Validation or GMP Microbiology book a meeting with the Intertek Team (41D57).
Whether your needs cover GLP/ GCP Bioanalysis, GMP Biopharma and Pharma analysis, GMP Auditing, Method development and Validation or GMP Microbiology book a meeting with the Intertek Team (41D57).
-------------------------------------
Meet the Intertek Team at ICSE 2011 - Stand 41D57
Are you reviewing your outsourcing requirements for 2012? For the critical stages of clinical development, marketing authorization through to manufacturing – Intertek provides a range of analysis, bioanalysis and auditing services to support your organization. To review your analysis outsourcing plans for the coming year and beyond book a meeting with the Intertek Pharmaceutical Services Team to discuss how we can assist.
GLP / GCP Bioanalysis GMP Pharmaceutical Analysis GMP Biopharmaceutical analysisGLP / GCP Analysis GMP Microbiological analysis GMP Pharmaceutical Auditing
During your confidential meetings you can discuss with our experts your long term plans to outsource individual projects or set up the groundwork for contracts covering ongoing testing. Intertek has a flexible set of contract types which we can apply to meeting your needs. You can find out about some of our specialist capabilities or alternatively discuss specific projects that you would like to get started.
Specialist capabilities:
Protein analysis and analytical support for Bioprocessing
And more...
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.